当前位置:首页 > 关于我们 > 创投导师 > 郭晓迪

郭晓迪 | Guo Xiaodi


18.jpg

郭晓迪

美国德克萨斯大学奥斯汀分校工业药学博士,国家特聘专家,中国药学会工业药剂专委会委员,国家重大专项负责人。美国Abrika, 美国普霖强生,深圳诺松联合创始人。现任浙江华海药业制剂研发院院长兼首席科学家,美国普霖斯通药业创始人兼首席科学官,在创新和高端仿制药制剂产品开发,中试放大生产和药品注册申报方面拥有全面丰富经验。在中美制药行业有超过30年经验,领导了中美市场的百余种创新制剂和仿制药产品开发,发表论文60多篇,专利20多个。

Guo Xiaodi

PHD of industrial pharmacy, University of Texas at Austin, USA, national special expert, member of industrial pharmacy committee of Chinese Pharmaceutical Society, and the person in charge of national major projects.  the co-founder of Abrika , PrinJohnson and Shenzhen Nuosong. He is now the president and chief scientist of Zhejiang Huahai Pharmaceutical Research and Development Institute, and the founder and chief scientist of PrinstonPharmaceutical,Inc, with rich experience in innovation and high-level generic medicine product development, pilot scale-up production and medicine registration. He has more than 30 years of experience in the pharmaceutical industry in China and the United States. He has led the development of more than 100 kinds of innovative preparations and generic medicine and published more than 60 papers and more than 20 patents.


0.194250s